|
gptkbp:instance_of
|
gptkb:healthcare_organization
|
|
gptkbp:associated_with
|
somatostatin
|
|
gptkbp:can_create
|
hormones
|
|
gptkbp:can_lead_to
|
gptkb:Company
malabsorption
|
|
gptkbp:can_metastasize_to
|
gptkb:theorem
|
|
gptkbp:caused_by
|
hyperglycemia
gastrointestinal symptoms
steatorrhea
|
|
gptkbp:complications
|
gptkb:theorem
|
|
gptkbp:exhibits
|
fatigue
nausea
jaundice
vomiting
diarrhea
|
|
gptkbp:first_described_by
|
1970s
|
|
gptkbp:has_achievements
|
metastasis
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
somatostatinomas
|
|
gptkbp:is_associated_with
|
gptkb:fandom
gptkb:Cushing's_syndrome
ascites
hypokalemia
hyperparathyroidism
hypoglycemia
thrombocytopenia
achlorhydria
hyperlipidemia
hypoalbuminemia
gallstones
portal hypertension
pancreatitis
cholecystitis
chronic diarrhea
insulinoma
VI Poma
carcinoid syndrome
glucagonoma
|
|
gptkbp:is_found_in
|
liver
pancreas
stomach
lymph nodes
spleen
intestines
|
|
gptkbp:is_monitored_by
|
serum somatostatin levels
|
|
gptkbp:is_often_used_in
|
adults
|
|
gptkbp:is_recognized_by
|
gptkb:MRI
CT scan
immunohistochemistry
endoscopic ultrasound
|
|
gptkbp:occurs_in
|
gptkb:multiple_endocrine_neoplasia_type_1
|
|
gptkbp:recognizes
|
biopsy
|
|
gptkbp:social_responsibility
|
imaging studies
|
|
gptkbp:symptoms
|
weight loss
abdominal pain
|
|
gptkbp:treatment
|
gptkb:hospital
radiation therapy
chemotherapy
somatostatin analogs
|
|
gptkbp:bfsParent
|
gptkb:multiple_endocrine_neoplasia_syndrome_type_2
|
|
gptkbp:bfsLayer
|
5
|